Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801007 · ClinicalTrials.gov registry record · NA
Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms
A NA study, sponsored by Microvention-Terumo.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT01801007 is a NA study that has completed, run by Microvention-Terumo. The registered enrollment target is 145 participants.
The verdict
NCT01801007, a NA study, has completed, sponsored by Microvention-Terumo.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) system when used in the treatment of wide-necked intracranial aneurysms.
Interventions
- DEVICE Flow Re-Direction Endoluminal Device (FRED)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2013-07 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01801007
The ClinicalTrials.gov registry entry for NCT01801007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Microvention-Terumo, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flow Re-Direction Endoluminal Device (FRED) is the first listed.
NCT01801007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01801007 about?
NCT01801007 is a clinical study titled "Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms". The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) system when used in the treatment of wide-necked intracranial aneurysms.
What is the current status of trial NCT01801007?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2013-07. Estimated completion is 2018-01.
What interventions are being tested in trial NCT01801007?
The interventions under investigation include: Flow Re-Direction Endoluminal Device (FRED) (DEVICE).
Who is sponsoring clinical trial NCT01801007?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.